Modern management of acute myocardial infarction

Heart and Stroke Facts, 1994, 1994 Statistical Supplement, 1 Norris, 1991, The changing natural history and prognosis of acute myocardial infarction, 87 DeWood, 1980, Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction, N Engl J Med, 303, 897, 10.1056/NEJM198010163031601 Willich, 1989, Increased morning incidence of myocardial infarction in the ISAM study: absence with prior β-adrenergic blockade, Circulation, 80, 853, 10.1161/01.CIR.80.4.853 Kono, 1996, Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy, J Am Coll Cardiol, 27, 774, 10.1016/0735-1097(95)00552-8 Davies, 1985, Plaque fissuring—the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina, Br Heart J, 53, 363, 10.1136/hrt.53.4.363 Richardson, 1989, Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques, Lancet, 2, 941, 10.1016/S0140-6736(89)90953-7 Ambrose, 1988, Angiographic progression of coronary artery disease and the development of myocardial infarction, J Am Coll Cardiol, 12, 56, 10.1016/0735-1097(88)90356-7 Moreno, 1994, Macrophage infiltration in acute coronary syndromes: implication for plaque rupture, Circulation, 90, 775, 10.1161/01.CIR.90.2.775 Thompson, 1995, Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris, N Engl J Med, 332, 635, 10.1056/NEJM199503093321003 Hamsten, 1995, Hemostatic function and coronary artery disease, N Engl J Med, 332, 677, 10.1056/NEJM199503093321011 Gibson, 1988, Non-Q-wave myocardial infarction: diagnosis, prognosis, and management, Curr Probl Cardiol, 13, 1 Bayer, 1986, Changing presentation of myocardial infarction with increasing old age, J Am Geriatr Soc, 34, 263, 10.1111/j.1532-5415.1986.tb04221.x Killip, 1967, Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients, Am J Cardiol, 20, 457, 10.1016/0002-9149(67)90023-9 Hands, 1988, Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block, Am Heart J, 116, 23, 10.1016/0002-8703(88)90245-1 Sgarbossa, 1996, Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block, N Engl J Med, 334, 481, 10.1056/NEJM199602223340801 Puleo, 1994, Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction, N Engl J Med, 331, 561, 10.1056/NEJM199409013310901 Thomson, 1995, Incremental value of the leukocyte differential and rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction, Ann Intern Med, 122, 335, 10.7326/0003-4819-122-5-199503010-00003 Mair, 1995, Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction, Clin Chem, 41, 1266, 10.1093/clinchem/41.9.1266 Wu, 1995, Meta-analysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart disease, Clin Chem, 41, 1228, 10.1093/clinchem/41.8.1228 Ravkilde, 1995, Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction: analysis of 28 months of follow-up in 196 patients, J Am Coll Cardiol, 25, 574, 10.1016/0735-1097(94)00430-X Christian, 1991, Effect of infarct location on myocardial salvage assessed by technetium-99m isonitrile, J Am Coll Cardiol, 17, 1303, 10.1016/S0735-1097(10)80140-8 Barilla, 1991, Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization, Am Heart J, 122, 1522, 10.1016/0002-8703(91)90267-L Reeder, 1995, Identification and treatment of complications of myocardial infarction, 70, 880 Reimer, 1977, The wavefront phenomenon of ischemia cell death. I. Myocardial infarct size vs duration of coronary occlusion in dogs, Circulation, 56, 786, 10.1161/01.CIR.56.5.786 Reimer, 1979, The “wavefront phenomenon” of myocardial ischemia cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow, Lab Invest, 40, 633 1994, Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients, Lancet, 343, 311, 10.1016/S0140-6736(94)91161-4 1990, GISSI-2. A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction, Lancet, 336, 65 1992, ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction, Lancet, 339, 753, 10.1016/0140-6736(92)91893-D The GUSTO Investigators, 1993, An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction, N Engl J Med, 329, 673, 10.1056/NEJM199309023291001 The GUSTO Angiographic Investigators, 1993, The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction, N Engl J Med, 329, 1615, 10.1056/NEJM199311253292204 Simoons, 1993, Tailored thrombolytic therapy: a perspective, Circulation, 88, 2556, 10.1161/01.CIR.88.6.2556 Collen, 1996, Fibrin-selective thrombolytic therapy for acute myocardial infarction, Circulation, 93, 857, 10.1161/01.CIR.93.5.857 Gersh, 1993, Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm—paradoxic or predictable?, Circulation, 88, 296, 10.1161/01.CIR.88.1.296 Weaver, 1993, Prehospital-initial vs hospital-initiated thrombolytic therapy, JAMA, 270, 1211, 10.1001/jama.1993.03510100061033 Edward, 1995, Quality of care for Medicare patients with acute myocardial infarction, JAMA, 273, 1509, 10.1001/jama.1995.03520430045037 O'Neill, 1986, A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction, N Engl J Med, 314, 812, 10.1056/NEJM198603273141303 DeWood, 1989, Direct PTCA versus intravenous rtPA in acute myocardial infarction: preliminary results from a prospective randomized trial, Circulation, 80, II Grines, 1993, A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction, N Engl J Med, 328, 673, 10.1056/NEJM199303113281001 Zjilstra, 1993, A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction, N Engl J Med, 328, 680, 10.1056/NEJM199303113281002 De Boer, 1993, Coronary angioplasty results in a lower rate of recurrent infarction and death when compared with streptokinase in patients with a myocardial infarction, Circulation, 88, I Gibbons, 1993, Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction, N Engl J Med, 328, 685, 10.1056/NEJM199303113281003 Ribeiro, 1993, Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction, J Am Coll Cardiol, 22, 376, 10.1016/0735-1097(93)90040-8 Elizaga, 1993, Primary coronary angioplasty versus systemic thrombolysis in acute anterior myocardial infarction: in-hospital results from a prospective randomized trial, Circulation, 88, I Lee, 1988, Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock, Circulation, 78, 1345, 10.1161/01.CIR.78.6.1345 Holmes, 1995, Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 Trial Experience, J Am Coll Cardiol, 26, 668, 10.1016/0735-1097(95)00215-P Hochman, 1995, Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry, Circulation, 91, 873, 10.1161/01.CIR.91.3.873 Michels, 1995, Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials, Circulation, 91, 476, 10.1161/01.CIR.91.2.476 Reeder, 1994, Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomized prospective trial, Mayo Clin Proc, 69, 5, 10.1016/S0025-6196(12)61604-8 Berger, 1994, Time to reperfusion with direct coronary angioplasty and thrombolytic therapy in acute myocardial infarction, Am J Cardiol, 73, 231, 10.1016/0002-9149(94)90225-9 Jhangiani, 1996, Community practice of primary angioplasty for myocardial infarction, J Am Coll Cardiol, 27, 61A, 10.1016/S0735-1097(96)80439-6 Mercho, 1996, Angiographic complications of primary angioplasty, J Am Coll Cardiol, 27, 61A, 10.1016/S0735-1097(96)80440-2 Cannon, 1996, Influence of door-to-balloon time on mortality in primary angioplasty results in 3,648 patients in the Second National Registry of Myocardial Infarction (NRMI-2), J Am Coll Cardiol, 27, 61A, 10.1016/S0735-1097(96)80441-4 Neuhaus, 1996, Primary PTCA in acute myocardial infarction: results from a German Multicenter registry, J Am Coll Cardiol, 27, 62A, 10.1016/S0735-1097(96)80442-6 Patel, 1996, Adverse outcomes accompanying primary angioplasty (PTCA) for acute myocardial infarction (AMI)—dangers of delay, J Am Coll Cardiol, 27, 62A, 10.1016/S0735-1097(96)80443-8 Caputo, 1996, The effect of institutional experience on the outcome of primary angioplasty for acute MI, J Am Coll Cardiol, 27, 62A, 10.1016/S0735-1097(96)80444-X Topol, 1987, A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction, N Engl J Med, 317, 581, 10.1056/NEJM198709033171001 Simoons, 1988, Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty, Lancet, 1, 197, 10.1016/S0140-6736(88)91062-8 1989, Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial, N Engl J Med, 320, 618, 10.1056/NEJM198903093201002 Topol, 1988, Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction, Circulation, 77, 1100, 10.1161/01.CIR.77.5.1100 Ellis, 1994, Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction, Circulation, 90, 2280, 10.1161/01.CIR.90.5.2280 Puleo, 1987, Creatine kinase isoform analysis in the detection and assessment of thrombolysis in man, Circulation, 75, 1162, 10.1161/01.CIR.75.6.1162 Langer, 1995, Non-invasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST Segment Monitoring Study, J Am Coll Cardiol, 25, 1552, 10.1016/0735-1097(95)00110-P De Bono, 1989, The SWIFT study of intervention versus conservative management after anistreplase thrombolysis [abstract], Circulation, 80, II Ellis, 1992, Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction: Treatment of Post-Thrombolytic Stenoses (TOPS) study group, Circulation, 86, 1400, 10.1161/01.CIR.86.5.1400 Topol, 1991, Coronary angiography after thrombolytic therapy for acute myocardial infarction, Ann Intern Med, 114, 877, 10.7326/0003-4819-114-10-877 Reiner, 1994, Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study, J Am Coll Cardiol, 24, 1439, 10.1016/0735-1097(94)90137-6 Jugdutt, 1981, Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog, Circulation, 63, 17, 10.1161/01.CIR.63.1.17 Jugdutt, 1988, Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications: effect of timing, dosage, and infarct location, Circulation, 78, 906, 10.1161/01.CIR.78.4.906 Yusuf, 1988, Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials, Lancet, 1, 1088, 10.1016/S0140-6736(88)91906-X 1994, GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction, Lancet, 343, 1115 1995, ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction, Lancet, 345, 669, 10.1016/S0140-6736(95)90865-X Woods, 1995, Mega-trials and management of acute myocardial infarction, Lancet, 346, 611, 10.1016/S0140-6736(95)91440-4 1981, The β-Blocker Heart Attack Trial, JAMA, 246, 2073, 10.1001/jama.1981.03320180063037 1981, Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction, N Engl J Med, 304, 801, 10.1056/NEJM198104023041401 1982, A randomized trial of propranolol in patients with acute myocardial Infarction. I. Mortality results, JAMA, 247, 1707, 10.1001/jama.1982.03320370021023 1984, Reduction of infarct size with the early use of timolol in acute myocardial infarction, N Engl J Med, 310, 9, 10.1056/NEJM198401053100103 1988, Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1, Lancet, 1, 921 1985, Metoprolol in acute myocardial infarction (MIAMI): a randomized placebo-controlled international trial, Eur Heart J, 6, 199, 10.1093/oxfordjournals.eurheartj.a061845 Lau, 1992, Cumulative meta-analysis of therapeutic trials for myocardial infarction, N Engl J Med, 327, 248, 10.1056/NEJM199207233270406 Held, 1989, Calcium channel blockers in acute myocardial infarction and unstable angina: an overview, Br Med J, 299, 1187, 10.1136/bmj.299.6709.1187 Gibson, 1986, Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind, randomized multicenter trial, N Engl J Med, 315, 423, 10.1056/NEJM198608143150704 1988, The effect of diltiazem on mortality and reinfarction after myocardial infarction, N Engl J Med, 319, 385, 10.1056/NEJM198808183190701 MacMahon, 1988, Effects of prophylactic lidocaine in suspected myocardial infarction: an overview of results from randomized, controlled trials, JAMA, 260, 1910, 10.1001/jama.1988.03410130118036 Hearse, 1978, Myocardial protection during ischaemic cardiac arrest, J Thorac Cardiovasc Surg, 75, 877, 10.1016/S0022-5223(19)39603-5 Teo, 1991, Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials, BMJ, 303, 1499, 10.1136/bmj.303.6816.1499 Woods, 1992, Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the Second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2), Lancet, 339, 1553, 10.1016/0140-6736(92)91828-V Woods, 1994, Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2), Lancet, 343, 816, 10.1016/S0140-6736(94)92024-9 Shechter, 1995, Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy, Am J Cardiol, 75, 321, 10.1016/S0002-9149(99)80546-3 Antman, 1995, Magnesium in acute MI, Circulation, 92, 2367, 10.1161/01.CIR.92.9.2367 Christensen, 1995, Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model, Circulation, 92, 2617, 10.1161/01.CIR.92.9.2617 Herzog, 1995, Timing of magnesium therapy affects experimental infarct size, Circulation, 92, 2622, 10.1161/01.CIR.92.9.2622 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383 Lonn, 1994, Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection, Circulation, 90, 2056, 10.1161/01.CIR.90.4.2056 Swedberg, 1992, Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction, N Engl J Med, 327, 678, 10.1056/NEJM199209033271002 1995, Oral captorpril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1), Lancet, 345, 686, 10.1016/S0140-6736(95)90866-8 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial (SAVE), N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 1994, The Trandolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population, Am J Cardiol, 73, 44C, 10.1016/0002-9149(94)90623-8 The Acute Infarction Ramipril Efficacy (AIRE) Study investigators, 1993, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure, Lancet, 342, 821 Ambrosioni, 1995, The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction, N Engl J Med, 332, 80, 10.1056/NEJM199501123320203 Kingma, 1994, Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction: results from the Captopril and Thrombolysis Study (CATS), Eur Heart J, 15, 898, 10.1093/oxfordjournals.eurheartj.a060608 Connolly, 1985, Coronary heart disease in residents of Rochester, Minnesota. III. Hospital and posthospital course of patients with transmural and subendocardial myocardial infarction, Mayo Clin Proc, 60, 375, 10.1016/S0025-6196(12)60846-5 Hutter, 1981, Nontransmural myocardial infarction: a comparison of hospital and late clinical course of patients with that of matched patients with anterior and transmural inferior myocardial infarction, Am J Cardiol, 48, 595, 10.1016/0002-9149(81)90136-3 Gibson, 1991, Non-Q-wave myocardial infarction: prognosis, changing incidence, and management, 284 The TIMI-IIIB Investigators, 1994, Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI-IIIB trial, Circulation, 89, 1545, 10.1161/01.CIR.89.4.1545 Anderson, 1995, J Am Coll Cardiol, 26, 1643, 10.1016/0735-1097(95)00404-1 Aguirre, 1995, Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis: results from the TIMI-II study, Circulation, 91, 2541, 10.1161/01.CIR.91.10.2541 Goldberg, 1991, Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988, N Engl J Med, 325, 1117, 10.1056/NEJM199110173251601 Forrester, 1976, Medical therapy of acute myocardial infarction by application of hemodynamic subsets, N Engl J Med, 295, 1356, 10.1056/NEJM197612092952406 Ratshin, 1972, Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction, Circulation, 45, 127, 10.1161/01.CIR.45.1.127 Nishimura, 1984, Role of two-dimensional echocardiography in the prediction of in-hospital complications after acute myocardial infarction, J Am Coll Cardiol, 4, 1080, 10.1016/S0735-1097(84)80125-4 Nishimura, 1986, Early repair of mechanical complications after acute myocardial infarction, JAMA, 256, 47, 10.1001/jama.1986.03380010051023 Montoya, 1980, Early repair of ventricular septal rupture after infarction, Am J Cardiol, 45, 345, 10.1016/0002-9149(80)90657-8 Radford, 1981, Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival, Circulation, 64, 545, 10.1161/01.CIR.64.3.545 Nishimura, 1983, Papillary muscle rupture complicating acute myocardial infarction: analysis of 17 patients, Am J Cardiol, 51, 373, 10.1016/S0002-9149(83)80067-8 López-Sendón, 1992, Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria, J Am Coll Cardiol, 19, 1145, 10.1016/0735-1097(92)90315-E Parry, 1992, Septal rupture after myocardial infarction: is very early surgery really worthwhile?, Eur Heart J, 13, 373, 10.1093/oxfordjournals.eurheartj.a060177 Batts, 1990, Postinfarction rupture of the left ventricular free wall: clinicopathologic correlates in 100 consecutive autopsy cases, Hum Pathol, 21, 530, 10.1016/0046-8177(90)90010-3 Lemery, 1992, Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention, Am J Cardiol, 70, 147, 10.1016/0002-9149(92)91266-7 John, 1974, Right ventricular infarction: clinical and hemodynamic features, Am J Cardiol, 33, 209, 10.1016/0002-9149(74)90276-8 White, 1987, Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction, Circulation, 76, 44, 10.1161/01.CIR.76.1.44 Goodfellow, 1995, Reversal of atropine-resistant atrioventricular block with intravenous aminophylline in the early phase of inferior wall acute myocardial infarction following treatment with streptokinase, Eur Heart J, 16, 862, 10.1093/oxfordjournals.eurheartj.a061008 Goldberg, 1992, Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester Heart Attack Study), Am J Cardiol, 69, 1135, 10.1016/0002-9149(92)90925-O Clemmensen, 1991, Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy, Am J Cardiol, 67, 225, 10.1016/0002-9149(91)90550-5 Berger, 1992, Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI-II, J Am Coll Cardiol, 20, 533, 10.1016/0735-1097(92)90004-7 Behard, 1993, Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis, Am Heart J, 125, 1622, 10.1016/0002-8703(93)90750-4 DeGuzman, 1983, What is the role of pacemakers in patients with coronary artery disease and conduction abnormalities?, Cardiovasc Clin, 13, 191 The Cardiac Arrhythmia Suppression Trial Investigators (CAST), 1989, Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction, N Engl J Med, 321, 406, 10.1056/NEJM198908103210629 Burkart, 1990, Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS), J Am Coll Cardiol, 16, 1711, 10.1016/0735-1097(90)90324-I Cairns, 1991, Post-myocardial infarction mortality in patients with ventricular premature depolarizations: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study, Circulation, 84, 550, 10.1161/01.CIR.84.2.550 Gomes, 1987, A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring, J Am Coll Cardiol, 10, 349, 10.1016/S0735-1097(87)80018-9 Sanz, 1982, Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study, N Engl J Med, 306, 1065, 10.1056/NEJM198205063061801 1990, ACC/AHA guidelines for the early management of patients with acute myocardial infarction [special report], Circulation, 82, 664 Hine, 1989, Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction, JAMA, 262, 3037, 10.1001/jama.1989.03430210079035 The Cardiac Arrhythmia Suppression Trial Investigators (CAST), 1989, Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction, N Engl J Med, 321, 406, 10.1056/NEJM198908103210629 Akhtar, 1990, CAST and beyond: implications of the Cardiac Arrhythmia Suppression Trial, Circulation, 81, 1123, 10.1161/01.CIR.81.3.1123 Pfisterer, 1992, Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function, Am J Cardiol, 69, 1399, 10.1016/0002-9149(92)90889-7 Murdaugh, 1988, Coronary heart disease in women: special considerations, Curr Probl Cardiol, 13, 73, 10.1016/0146-2806(88)90002-3 Kannel, 1987, Incidence and prognosis of myocardial infarction in women: the Framingham Study, 208 Tofler, 1987, Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women, J Am Coll Cardiol, 9, 473, 10.1016/S0735-1097(87)80038-4 Vaccarino, 1995, Sex differences in mortality after myocardial infarction: is there evidence for an increased risk for women?, Circulation, 91, 1861, 10.1161/01.CIR.91.6.1861 Weaver, 1996, Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy, JAMA, 275, 777, 10.1001/jama.1996.03530340041027 Bigger, 1986, Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction, Am J Cardiol, 58, 1151, 10.1016/0002-9149(86)90374-7 Denniss, 1986, Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction, Circulation, 74, 731, 10.1161/01.CIR.74.4.731 Vatterott, 1988, Signal-averaged electrocardiography: a new noninvasive test to identify patients at risk for ventricular arrhythmias, 63, 931 Odemuyiwa, 1992, Influence of age on the relation between heart rate variability, left ventricular ejection fraction, frequency of ventricular extrasystoles, and sudden death after myocardial infarction, Br Heart J, 67, 387, 10.1136/hrt.67.5.387 Gomes, 1989, The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study, J Am Coll Cardiol, 13, 377, 10.1016/0735-1097(89)90515-9 Hillis, 1990, Risk stratification before thrombolytic therapy in patients with acute myocardial infarction, J Am Coll Cardiol, 16, 313, 10.1016/0735-1097(90)90579-E Lee, 1995, Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients, Circulation, 91, 1659, 10.1161/01.CIR.91.6.1659 Volpi, 1993, Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base, Circulation, 88, 416, 10.1161/01.CIR.88.2.416 Newby, 1996, Early discharge in the thrombolytic era: analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) Trial, J Am Coll Cardiol, 27, 625, 10.1016/0735-1097(95)00513-7 Reeder, 1995, Acute myocardial infarction: risk stratification in the thrombolytic era, 70, 87